Cited by 2,542Cancer Genomics and DiagnosticsCancer Cells and MetastasisMicrofluidic and Bio-sensing Technologies

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

Allard, W. Jeffrey, Matera, Jeri, Miller, M. Craig, Repollet, Madeline, Connelly, Mark C., Rao, Chandra, Tibbe, Arjan G. J., Uhr, Jonathan W., Terstappen, Leon W. M. M.·2004·Clinical Cancer Research

DOI 10.1158/1078-0432.ccr-04-0378

Published version of a preprint

Open this paper in CoChat — free account

Abstract

PURPOSE: The purpose of this study was to determine the accuracy, precision, and linearity of the CellSearch system and evaluate the number of circulating tumor cells (CTCs) per 7.5 mL of blood in healthy subjects, patients with nonmalignant diseases, and patients with a variety of metastatic carcinomas. EXPERIMENTAL DESIGN: The CellSearch system was used to enumerate CTCs in 7.5 mL of blood. Blood samples spiked with cells from tumor cell lines were used to establish analytical accuracy, reproducibility, and linearity. Prevalence of CTCs was determined in blood from 199 patients with nonmalignant diseases, 964 patients with metastatic carcinomas, and 145 healthy donors. RESULTS: Enumeration of spiked tumor cells was linear over the range of 5 to 1,142 cells, with an average recovery of >/=85% at each spike level. Only 1 of the 344 (0.3%) healthy and nonmalignant disease subjects had >/=2 CTCs per 7.5 mL of blood. In 2,183 blood samples from 964 metastatic carcinoma patients, CTCs ranged from 0 to 23,618 CTCs per 7.5 mL (mean, 60 +/- 693 CTCs per 7.5 mL), and 36% (781 of 2,183) of the specimens had >/=2 CTCs. Detection of >/=2 CTCs occurred at the following rates: 57% (107 of 188) of prostate cancers, 37% (489 of 1,316) of breast cancers, 37% (20 of 53) of ovarian cancers, 30% (99 of 333) of colorectal cancers, 20% (34 of 168) of lung cancers, and 26% (32 of 125) of other cancers. CONCLUSIONS: The CellSearch system can be standardized across multiple laboratories and may be used to determine the clinical utility of CTCs. CTCs are extremely rare in healthy subjects and patients with nonmalignant diseases but present in various metastatic carcinomas with a wide range of frequencies.

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-04-0378

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736
Statistics for Experimenters
Addelman, S., Box, G. E. P., Hunter, W. G., & Hunter, J. S. (1979) · Technometrics · doi:10.2307/1267766 · Cited by 6,753
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,602
Detection and characterization of carcinoma cells in the blood
Racila, E. V., Euhus, D., Weiss, A. J., Rao, C., McConnell, J. D., Terstappen, L. W. M. M., & Uhr, J. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4589 · Cited by 713
Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques [see comments]
Ross, A., Cooper, B., Lazarus, H. M., Mackay, W., Moss, T., Ciobanu, N., Tallman, M. S., Kennedy, M., Davidson, N., & Sweet, D. (1993) · Blood · doi:10.1182/blood.v82.9.2605.bloodjournal8292605 · Cited by 487
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]
Brugger, W., Bross, K., Glatt, M., Weber, F., Mertelsmann, R. H., & Kanz, L. (1994) · Blood · doi:10.1182/blood.v83.3.636.636 · Cited by 440
Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]
Brugger, W., Bross, K., Glatt, M., et al. (1994) · Blood · doi:10.1182/blood.v83.3.636.bloodjournal833636 · Cited by 357
Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues.
Momburg, F., Moldenhauer, G., Hämmerling, G. J., & Möller, P. (1987) · PubMed · Cited by 328
Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer
Kugaya, A., Akechi, T., Okuyama, T., Nakano, T., Mikami, I., Okamura, H., & Uchitomi, Y. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12 · Cited by 309
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells
Borgen, E., Naume, B., Nesland, J. M., Kvalheim, G., Beiske, K., Fodstad, Ø., Diel, I., Solomayer, E., Theocharous, P., Coombes, R. C., et al. (1999) · Cytotherapy · doi:10.1080/0032472031000141283 · Cited by 263

Show all 30 references

Research works printed but not linked: 8

Soria JC, Gauthier LR, Raymond E, et al Molecular detection of telomerase positive circulating epithelial cells in metastatic breast cancer patients. Clin Cancer Res 1999;5:971-5.
Fehm T, Sagalowsky A, Clifford E, et al Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 2002;8:2073-84.
Kagan M, Howard D, Bendele T, et al A sample preparation and analysis system for identification of circulating tumor cells. J Clin Ligand Assay 2002;25:104-10.
Rao C, Rutner H, Hermann M, Russell T, Terstappen LWMM. Preservation of blood specimens to prevent breakdown of circulating tumor cells. Proc Am Assoc Cancer Res 2002;43:734
Allard WJ, Hayes DF, Repollet MI, et al A cellular preservative improves the specificity and yield of circulating tumor cells in carcinoma patients[abstract A3482]. Proc Am Soc Clin Oncol 2003;22:866
Motulsky H. The confidence interval of counted variables. Intuitive biostatistics 1995p. 245-9. Oxford University Press New York
Miller MC, Gross S, Allard WJ, et al Circulating tumor cells (CTCs) predict survival in patients with metastatic prostate cancer[abstract A5270]. Proc Am Assoc Cancer Res 2004;45:1215
Cristofanilli M, Reuben JM, Fritsche HA, et al Circulating tumor cells (CTCs): a novel prognostic factor for newly diagnosed metastatic breast cancer (MBC)[abstract A1349]. Proc Am Assoc Cancer Res 2003;44:1349

Sorted by citations

Items 401–500 of 1,004

The Role of Circulating Tumor Cells in the Metastatic Cascade: Biology, Technical Challenges, and Clinical Relevance
Dianat‐Moghadam, H., Azizi, M., Eslami‐S, Z., Cortés‐Hernández, L. E., Heidarifard, M., Nouri, M., & Alix‐Panabières, C. (2020) · Cancers · doi:10.3390/cancers12040867 · Cited by 103
Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma
Yang, J. D., Campion, M. B., Liu, M., Chaiteerakij, R., Giama, N. H., Mohammed, H. A., Zhang, X., Hu, C., Campion, V. L., Jen, J., et al. (2015) · Hepatology · doi:10.1002/hep.27944 · Cited by 96
Advances in single-cell RNA sequencing and its applications in cancer research
Zhu, S., Qing, T., Zheng, Y., Li, J., & Shi, L. M. (2017) · Oncotarget · doi:10.18632/oncotarget.17893 · Cited by 98
Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids
Okajima, W., Komatsu, S., Ichikawa, D., Miyamae, M., Ohashi, T., Imamura, T., Kiuchi, J., Nishibeppu, K., Arita, T., Konishi, H., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i31.5650 · Cited by 98
Circulating Tumor Cells: Diagnostic and Therapeutic Applications
Lin, E., Cao, T. M., Nagrath, S., & King, M. R. (2018) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-062117-120947 · Cited by 100
Molecular characterisation and liquid biomarkers in Carcinoma of Unknown Primary (CUP): taking the ‘U’ out of ‘CUP’
Conway, A., Mitchell, C. L., Kilgour, E., Brady, G., Dive, C., & Cook, N. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0332-2 · Cited by 95
Monitoring Drug-Induced γH2AX as a Pharmacodynamic Biomarker in Individual Circulating Tumor Cells
Wang, L. H., Pfister, T. D., Parchment, R. E., Kummar, S., Rubinstein, L., Evrard, Y. A., Gutierrez, M. E., Murgo, A. J., Tomaszewski, J. E., Doroshow, J. H., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2799 · Cited by 98
Magneto‐Controllable Capture and Release of Cancer Cells by Using a Micropillar Device Decorated with Graphite Oxide‐Coated Magnetic Nanoparticles
Yu, X., He, R., Li, S., Cai, B., Zhao, L., Liao, L., Liu, W., Zeng, Q., Wang, H., Guo, S., et al. (2013) · Small · doi:10.1002/smll.201300169 · Cited by 97
Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer
Paris, P. L., Kobayashi, Y., Zhao, Q., Zeng, W., Sridharan, S., Fan, T. M., Adler, H. L., Yera, E. R., Zarrabi, M. H., Zucker, S., et al. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.12.007 · Cited by 98
Integrative analyses of scRNA-seq and scATAC-seq reveal CXCL14 as a key regulator of lymph node metastasis in breast cancer
Xu, K., Zhang, W., Wang, C., Hu, L., Wang, R., Wang, C., Tang, L., Zhou, G., Zou, B., Xie, H., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab042 · Cited by 97
Circulating Tumor Cells in Pulmonary Venous Blood of Primary Lung Cancer Patients
Okumura, Y., Tanaka, F., Yoneda, K., Hashimoto, M., Takuwa, T., Kondo, N., & Hasegawa, S. (2009) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2009.03.073 · Cited by 100
A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer
Tien, Y., Kuo, H.-C., Ho, B.-I., Chang, M., Chang, Y., Cheng, M., Chen, H.-L., Liang, T.-Y., Wang, C.-F., Huang, C.-Y., et al. (2016) · Medicine · doi:10.1097/md.0000000000003407 · Cited by 94
Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer
Zhao, R., Cai, Z., Li, S., Cheng, Y., Gao, H., Liu, F., Wu, S., Liu, S., Dong, Y., Zheng, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14065 · Cited by 94
Review: Microfluidics technologies for blood-based cancer liquid biopsies
Sun, Y., Haglund, T. A., Rogers, A. J., Ghanim, A. F., & Sethu, P. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2017.12.050 · Cited by 94
EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer
Lindsay, C. R., Blackhall, F. H., Carmel, A., Fernández‐Gutiérrez, F., Gazzaniga, P., Groen, H. J. M., Hiltermann, T. J. N., Krebs, M., Loges, S., López‐López, R., et al. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.04.019 · Cited by 95
Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer
Pearl, M. L., Zhao, Q., Yang, J., Dong, H., Tulley, S., Zhang, Q., Golightly, M. G., Zucker, S., & Chen, W. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.06.013 · Cited by 92
Mobilization of Viable Tumor Cells Into the Circulation During Radiation Therapy
Martin, O. A., Anderson, R. L., Russell, P. A., Cox, R. A., Ivashkevich, A. N., Swierczak, A., Doherty, J. P., Jacobs, D., Smith, J., Siva, S., et al. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.10.033 · Cited by 96
The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients
der Auwera, I. V., Elst, H., Laere, S. V., Maes, H., Huget, P., van Dam, P. A., Marck, E. A. V., Vermeulen, P. B., & Dirix, L. Y. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605013 · Cited by 94
Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer
Riva, F., Dronov, O. I., Khomenko, D. I., Huguet, F., Louvet, C., Mariani, P., Stern, M., Lantz, O. J., Proudhon, C., Pierga, J., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.01.006 · Cited by 97
Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis
Barradas, A. M. C., & Terstappen, L. W. M. M. (2013) · Cancers · doi:10.3390/cancers5041619 · Cited by 93
Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer
Tang, Y., Qiao, G., Xu, E., Xuan, Y., Liao, M., & Yin, G. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s142149 · Cited by 97
Liquid biopsy: one cell at a time
Lim, S. B., Lee, W. D., Vasudevan, J., Lim, W., & Lim, C. T. (2019) · npj Precision Oncology · doi:10.1038/s41698-019-0095-0 · Cited by 93
Liquid Biopsy: A Distinctive Approach to the Diagnosis and Prognosis of Cancer
Hirahata, T., Quraish, R. U., Quraish, A. U., Quraish, S. U., Naz, M., & Razzaq, M. A. (2022) · Cancer Informatics · doi:10.1177/11769351221076062 · Cited by 95
Detection of circulating tumor cells in patients with urothelial cancer
Gallagher, D. J., Milowsky, M. I., Ishill, N. M., Trout, A., Boyle, M. G., Riches, J. C., Fleisher, M., & Bajorin, D. F. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn627 · Cited by 92
Molecular Pathogenesis of Neuroendocrine Tumors: Implications for Current and Future Therapeutic Approaches
Öberg, K., Casanovas, O., Castano, J. P., Chung, D. C., Fave, G. D., Denèfle, P., Harris, P. A., Khan, M. S., Kulke, M. H., Scarpa, A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3458 · Cited by 91
Circulating and Disseminated Tumor Cells in the Management of Breast Cancer
Ross, J. S., & Slodkowska, E. A. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcpji7deolkcs6f · Cited by 91
Optical Quantification of Cellular Mass, Volume, and Density of Circulating Tumor Cells Identified in an Ovarian Cancer Patient
Phillips, K. G., Velasco, C. R., Li, J., Kolatkar, A. R., Luttgen, M. S., Bethel, K. J., Duggan, B. D., Kühn, P., & McCarty, O. J. T. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00072 · Cited by 91
Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy
Simon, M., Stefan, N., Plückthun, A., & Zangemeister‐Wittke, U. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.759938 · Cited by 95
A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroups
Lindsay, C. R., Faugeroux, V., Michiels, S., Pailler, E., Facchinetti, F., Ou, D., Bluthgen, M. V., Pannet, C., Ngo‐Camus, M., Bescher, G., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx156 · Cited by 92
Liquid Biopsy Preservation Solutions for Standardized Pre-Analytical Workflows—Venous Whole Blood and Plasma
Grölz, D., Hauch, S., Schlumpberger, M., Günther, K., Voß, T., Sprenger‐Haussels, M., & Oelmüller, U. (2018) · Current Pathobiology Reports · doi:10.1007/s40139-018-0180-z · Cited by 96
StarDist Image Segmentation Improves Circulating Tumor Cell Detection
Stevens, M., Nanou, A., Terstappen, L. W. M. M., Driemel, C., Stoecklein, N. H., & Coumans, F. A. W. (2022) · Cancers · doi:10.3390/cancers14122916 · Cited by 90
Circulating tumor cells detected by lab-on-a-disc: Role in early diagnosis of gastric cancer
Kang, H. M., Kim, G. H., Jeon, H. K., Kim, D. H., Jeon, T. Y., Park, D. Y., Jeong, H., Chun, W., Kim, M. H., Park, J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180251 · Cited by 91
Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer
Kidess, E., Liu, H. E., Triboulet, M. M., Che, J., Ramani, V. C., Visser, B. C., Poultsides, G. A., Longacre, T. A., Marziali, A., Vysotskaia, V. S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13350 · Cited by 89
Circulating tumor cells: Blood-based detection, molecular biology, and clinical applications
Dai, C. S., Mishra, A., Edd, J., Toner, M., Maheswaran, S., & Haber, D. A. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.07.008 · Cited by 104
High-purity capture of CTCs based on micro-beads enhanced isolation by size of epithelial tumor cells (ISET) method
Sun, N., Li, X., Wang, Z., Li, Y., & Pei, R. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.11.026 · Cited by 89
Circulating Tumors Cells as Biomarkers
Danila, D. C., Pantel, K., Fleisher, M., & Scher, H. I. (2011) · The Cancer Journal · doi:10.1097/ppo.0b013e31823e69ac · Cited by 89
Real-time Detection of Breast Cancer Cells Using Peptide-functionalized Microcantilever Arrays
Etayash, H., Jiang, K., Azmi, S., Thundat, T. G., & Kaur, K. (2015) · Scientific Reports · doi:10.1038/srep13967 · Cited by 91
Perspectives on liquid biopsy for label‐free detection of “circulating tumor cells” through intelligent lab‐on‐chips
Miccio, L., Cimmino, F., Kurelac, I., Villone, M. M., Bianco, V., Memmolo, P., Merola, F., Mugnano, M., Capasso, M., Iolascon, A., et al. (2020) · Open Research (University of Surrey) · doi:10.1002/viw.20200034 · Cited by 87
Machine learning assisted dual-modal SERS detection for circulating tumor cells
Zhang, C., Xu, L., Miao, X., Zhang, D., Xie, Y., Hu, Y., Zhang, Z., Wang, X., Wu, X., Liu, Z., et al. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116897 · Cited by 89
Two-hundredfold volume concentration of dilute cell and particle suspensions using chip integrated multistage acoustophoresis
Antfolk, M., & Laurell, T. (2012) · Lab on a Chip · doi:10.1039/c2lc40629b · Cited by 89
Three‐Dimensional Graphene Composite Macroscopic Structures for Capture of Cancer Cells
Yin, S., Wu, Y., Hu, B., Wang, Y., Cai, P., Tan, C. K., Qi, D., Zheng, L., Leow, W. R., Tan, N. S., et al. (2013) · Advanced Materials Interfaces · doi:10.1002/admi.201300043 · Cited by 89
Efficiency of whole genome amplification of single circulating tumor cells enriched by CellSearch and sorted by FACS
Swennenhuis, J. F., Reumers, J., Thys, K., Aerssens, J., & Terstappen, L. W. M. M. (2013) · Genome Medicine · doi:10.1186/gm510 · Cited by 88
Enrichment of circulating head and neck tumour cells using spiral microfluidic technology
Kulasinghe, A., Tran, T., Blick, T., O'Byrne, K. J., Thompson, E. W., Warkiani, M. E., Nelson, C. C., Kenny, L., & Punyadeera, C. (2017) · Scientific Reports · doi:10.1038/srep42517 · Cited by 88
EpCAMhigh and EpCAMlow circulating tumor cells in metastatic prostate and breast cancer patients
de Wit, S., Manicone, M., Rossi, E. M. C., Lampignano, R., Yang, L., Zill, B., Rengel-Puertas, A., Ouhlen, M., Crespo, M., Berghuis, A. M. S., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26298 · Cited by 88
AXL signaling in cancer: from molecular insights to targeted therapies
Yadav, M., Sharma, A., Patne, K., Tabasum, S., Suryavanshi, J., Rawat, L., Machaalani, M., Eid, M., Singh, R. P., Choueiri, T. K., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02121-7 · Cited by 99
Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method
Sawabata, N., Okumura, M., Utsumi, T., Inoue, M., Shiono, H., Minami, M., Nishida, T., & Sawa, Y. (2007) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-007-0101-2 · Cited by 88
Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First-Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study
Sastre, J., Maestro, M. L., Gómez‐España, A., Rivera, F., Valladares, M., Massutí, B., Benavides, M., Gallén, M., Marcuello, E., Abad, A., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0048 · Cited by 88
Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast Cancer
Mego, M., Gao, H., Cohen, E. N., Anfossi, S., Giordano, A., Sanda, T., Fouad, T. M., Giorgi, U. D., Giuliano, M., Woodward, W. A., et al. (2016) · Journal of Cancer · doi:10.7150/jca.13098 · Cited by 88
Liquid biopsy for cancer: review and implications for the radiologist
Underwood, J. J., Quadri, R. S., Kalva, S. P., Shah, H., Sanjeeviah, A. R., Beg, M. S., & Sutphin, P. D. (2020) · Radiology · doi:10.1148/radiol.2019182584 · Cited by 87
Label-free single-cell separation and imaging of cancer cells using an integrated microfluidic system
Antfolk, M., Kim, S. H., Koizumi, S., Fujii, T., & Laurell, T. (2017) · Scientific Reports · doi:10.1038/srep46507 · Cited by 87
Methods for detecting circulating cancer stem cells (CCSCs) as a novel approach for diagnosis of colon cancer relapse/metastasis
Kantara, C., O’Connell, M. R., Luthra, G. K., Gajjar, A. H., Sarkar, S., Ullrich, R. L., & Singh, P. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.133 · Cited by 87
The clinical significance of circulating tumor cells in non-metastatic colorectal cancer – A review
Thorsteinsson, M., & Jess, P. (2011) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2011.01.025 · Cited by 87
Circulating Tumor Cells in Patients with Recurrent or Metastatic Head and Neck Carcinoma: Prognostic and Predictive Significance
Grisanti, S., Almici, C., Consoli, F., Buglione, M., Verardi, R., Villaret, A. B., Bianchetti, A., Ciccarese, C., Mangoni, M., Ferrari, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103918 · Cited by 86
Key Enabling Technologies for Point-of-Care Diagnostics
Primiceri, E., Chiriacò, M. S., Notarangelo, F. M., Crocamo, A., Ardissino, D., Cereda, M., Bramanti, A. P., Bianchessi, M. A., Giannelli, G., & Maruccio, G. (2018) · Sensors · doi:10.3390/s18113607 · Cited by 89
Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA
Lee, J., Park, S. S., Lee, Y. K., Norton, J. A., & Jeffrey, S. S. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12537 · Cited by 88
Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survival
Nanou, A., Miller, M. C., Zeune, L. L., de Wit, S., Punt, C. J. A., Groen, H. J. M., Hayes, D. F., Bono, J. S. D., & Terstappen, L. W. M. M. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0726-9 · Cited by 85
Coupled liquid biopsy and bioinformatics for pancreatic cancer early detection and precision prognostication
Hou, J., Li, X., & Xie, K. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01309-7 · Cited by 86
Efficient capture of circulating tumor cells with a novel immunocytochemical microfluidic device
Dickson, M. N., Tsinberg, P., Tang, Z., Bischoff, F. Z., Wilson, T. G., & Leonard, E. F. (2011) · Biomicrofluidics · doi:10.1063/1.3623748 · Cited by 86
Relationship between circulating tumour cell count and prognosis following chemotherapy in patients with advanced non‐small‐cell lung cancer
Zhang, Z., Xiao, Y., Zhao, J., Chen, M., Xu, Y., Zhong, W., Xing, J., & Wang, M. (2015) · Respirology · doi:10.1111/resp.12696 · Cited by 85
Patient‑derived xenograft mouse models: A high fidelity tool for individualized medicine (Review)
Xu, C., Li, X., Liu, P., Li, M., & Luo, F. (2018) · Oncology Letters · doi:10.3892/ol.2018.9583 · Cited by 86
Microfluidics as an Enabling Technology for Personalized Cancer Therapy
Mathur, L., Ballinger, M., Utharala, R., & Merten, C. A. (2019) · Small · doi:10.1002/smll.201904321 · Cited by 83
Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer
Malani, R., Fleisher, M., Kumthekar, P., Lin, X., Omuro, A. M. P., Groves, M. D., Lin, N., Melisko, M., Lassman, A. B., Jeyapalan, S. A., et al. (2020) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03555-z · Cited by 84
The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study
Molife, L. R., Fong, P. C. C., Paccagnella, L., Reid, A. H. M., Shaw, H. M., Vidal, L., Arkenau, H., Karavasilis, V., Yap, T. A., Olmos, D., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605767 · Cited by 85
Fusion-Derived Epithelial Cancer Cells Express Hematopoietic Markers and Contribute to Stem Cell and Migratory Phenotype in Ovarian Carcinoma
Ramakrishnan, M., Mathur, S. R., & Mukhopadhyay, A. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0896 · Cited by 84
Circulating Tumor Cells From Well-Differentiated Lung Adenocarcinoma Retain Cytomorphologic Features of Primary Tumor Type
Marrinucci, D. C., Bethel, K. J., Luttgen, M. S., Bruce, R. H., Nieva, J. J., & Kühn, P. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.9.1468 · Cited by 82
Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer
Sharp, A., Welti, J. C., Lambros, M. B. K., Dolling, D. I., Rodrigues, D. N., Pope, L., Aversa, C., Figueiredo, I., Fraser, J. A., Ahmad, Z., et al. (2019) · European Urology · doi:10.1016/j.eururo.2019.04.006 · Cited by 85
Liquid biopsy using the nanotube-CTC-chip: capture of invasive CTCs with high purity using preferential adherence in breast cancer patients
Loeian, M. S., Aghaei, S. M., Farhadi, F., Rai, V., Yang, H. W., Johnson, M. D., Aqil, F., Mandadi, M., Rai, S. N., & Panchapakesan, B. (2019) · Lab on a Chip · doi:10.1039/c9lc00274j · Cited by 83
Real‐Time Stain‐Free Classification of Cancer Cells and Blood Cells Using Interferometric Phase Microscopy and Machine Learning
Nissim, N., Dudaie, M., Barnea, I., & Shaked, N. T. (2020) · Cytometry Part A · doi:10.1002/cyto.a.24227 · Cited by 83
In vivo flow cytometry reveals a circadian rhythm of circulating tumor cells
Zhu, X., Suo, Y., Fu, Y., Zhang, F., Ding, N., Pang, K., Xie, C., Weng, X., Tian, M., He, H., et al. (2021) · Light Science & Applications · doi:10.1038/s41377-021-00542-5 · Cited by 87
Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact
Honoré, N., Galot, R., van Marcke, C., Limaye, N., & Machiels, J. (2021) · Cancers · doi:10.3390/cancers13215364 · Cited by 88
Current advances in noninvasive methods for the diagnosis of oral squamous cell carcinoma: a review
Wang, S., Yang, M., Li, R., & Bai, J. (2023) · European journal of medical research · doi:10.1186/s40001-022-00916-4 · Cited by 90
Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study
Bidard, F., Hajage, D., Bachelot, T., Delaloge, S., Brain, E. G. C., Campone, M., Cottu, P. H., Beuzeboc, P., Rolland, E., Mathiot, C., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3114 · Cited by 83
HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer
Lang, J. E., Mosalpuria, K., Cristofanilli, M., Krishnamurthy, S., Reuben, J. M., Singh, B., Bedrosian, I., Meric‐Bernstam, F., & Lucci, A. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9951-2 · Cited by 83
Isolation and enrichment of circulating biomarkers for cancer screening, detection, and diagnostics
Hyun, K.-A., Kim, J., Gwak, H., & Jung, H. (2015) · The Analyst · doi:10.1039/c5an01762a · Cited by 81
Cell Separations and Sorting
Witek, M. A., Freed, I. M., & Soper, S. A. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b05357 · Cited by 82
Evaluation of a Panel of Tumor Markers for Molecular Detection of Circulating Cancer Cells in Women with Suspected Breast Cancer
Reinholz, M. M., Nibbe, A. M., Jonart, L. M., Kitzmann, K. A., Suman, V. J., Ingle, J. N., Houghton, R. L., Zehentner, B. K., Roche, P. C., & Lingle, W. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1483 · Cited by 82
Looking back, to the future of circulating tumor cells
Friedlander, T. W., Premasekharan, G., & Paris, P. L. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.011 · Cited by 81
Detection of Circulating Tumor Cells in Metastatic and Clinically Localized Urothelial Carcinoma
Flaig, T. W., Wilson, S., van Bokhoven, A., Varella‐Garcia, M., Wolfe, P., MARONI, P. D., Genova, E. E., Morales, D., & Lucia, M. S. (2011) · Urology · doi:10.1016/j.urology.2011.05.045 · Cited by 83
Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion
Laget, S., Broncy, L., Hormigos, K., Dhingra, D. M., BenMohamed, F., Capiod, T., Østerås, M., Farinelli, L., Jackson, S. M., & Paterlini-Bréchot, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169427 · Cited by 81
Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions
Kučera, R., Pecen, L., Topolčan, O., Dahal, A. R., Costigliola, V., Giordano, F. A., & Golubnitschaja, O. (2020) · The EPMA Journal · doi:10.1007/s13167-020-00214-1 · Cited by 81
Biomarkers and Lung Cancer Early Detection: State of the Art
Dama, E., Colangelo, T., Fina, E., Cremonesi, M., Kallikourdis, M., Veronesi, G., & Bianchi, F. (2021) · Cancers · doi:10.3390/cancers13153919 · Cited by 84
Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges
Seyhan, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147974 · Cited by 87
An electrical biosensor for the detection of circulating tumor cells
Chung, Y.-K., Reboud, J., Lee, K. C., Lim, H. M., Lim, P. Y., Wang, K. Y., Tang, K. C., Ji, H., & Chen, Y. (2010) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2010.10.048 · Cited by 81
Leukocytes as carriers for targeted cancer drug delivery
Mitchell, M. J., & King, M. R. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.966684 · Cited by 82
Circulating tumor cells in solid tumor in metastatic and localized stages.
Maestro, L. M., Sastre, J., Rafael, S., Veganzones, S., Vidaurreta, M., Martín, M., Olivier, C., de la Orden, V., García-Sáenz, J. Á., Alfonso, R., et al. (2009) · PubMed · Cited by 81
Nanotechnology for Enrichment and Detection of Circulating Tumor Cells
Bhana, S., Wang, Y., & Huang, X. (2015) · Nanomedicine · doi:10.2217/nnm.15.32 · Cited by 82
Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer
Mu, Z., Benali-Furet, N., Uzan, G., Znaty, A., Ye, Z., Paolillo, C., Wang, C., Austin, L., Rossi, G., Fortina, P. M., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101665 · Cited by 80
Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer
Cortés‐Hernández, L. E., Eslami‐S, Z., & Alix‐Panabières, C. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.07.008 · Cited by 84
Enrichment of circulating tumor cells from a large blood volume using leukapheresis and elutriation: Proof of concept
Eifler, R. L., Lind, J., Falkenhagen, D., Weber, V., Fischer, M. B., & Zeillinger, R. (2010) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20560 · Cited by 80
Compartmental Differences of Circulating Tumor Cells in Colorectal Cancer
Rahbari, N. N., Bork, U., Kircher, A., Nimitz, T., Schölch, S., Kahlert, C., Schmidt, T., Steinert, G., Ulrich, A. B., Reißfelder, C., et al. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2178-1 · Cited by 80
Circulating tumor cells as liquid biopsy markers in cancer patients
Smit, D. J., & Pantel, K. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101258 · Cited by 81
FISH-based determination of HER2 status in circulating tumor cells isolated with the microfluidic CEE™ platform
Mayer, J. A., Pham, T., Wong, K. L., Scoggin, J., Sales, E., Clarin, T., Pircher, T. J., Mikolajczyk, S. D., Cotter, P. D., & Bischoff, F. Z. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.10.011 · Cited by 79
Changing levels of circulating tumor cells in monitoring chemotherapy response in patients with metastatic breast cancer.
Hartkopf, A. D., Wagner, P., Wallwiener, D. R., Fehm, T. N., & Rothmund, R. (2011) · PubMed · Cited by 79
Dual-Aptamer Modification Generates a Unique Interface for Highly Sensitive and Specific Electrochemical Detection of Tumor Cells
Qu, L., Xu, J., Tan, X., Liu, Z., Xu, L., & Peng, R. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am5006783 · Cited by 79
Circulating Tumor Cell Isolation and Analysis
Zhang, J., Chen, K., & Fan, Z. H. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2016.03.003 · Cited by 81
Clinical Validity of Detecting Circulating Tumor Cells by AdnaTest Assay Compared With Direct Detection of Tumor mRNA in Stabilized Whole Blood, as a Biomarker Predicting Overall Survival for Metastatic Castration-Resistant Prostate Cancer Patients
Danila, D. C., Samoila, A., Patel, C. N., Schreiber, N. A., Herkal, A., Anand, A., Bastos, D. A., Heller, G., Fleisher, M., & Scher, H. I. (2016) · The Cancer Journal · doi:10.1097/ppo.0000000000000220 · Cited by 82
The prognostic and diagnostic value of circulating tumor cells in bladder cancer and upper tract urothelial carcinoma: a meta-analysis of 30 published studies
Zhang, Z., Fan, W., Deng, Q., Tang, S., Wang, P., Xu, P., Wang, J., & Yu, M. (2017) · Oncotarget · doi:10.18632/oncotarget.18521 · Cited by 79
Magnetic carbon nanotubes: preparation, physical properties, and applications in biomedicine
Samadishadlou, M., Farshbaf, M., Annabi, N., Kavetskyy, T. S., Khalilov, R. I., Saghfi, S., Akbarzadeh, A., & Mousavi, S. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1389746 · Cited by 83
Circulating tumor microemboli: Progress in molecular understanding and enrichment technologies
Umer, M., Vaidyanathan, R., Nguyen, N., & Shiddiky, M. J. A. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.05.002 · Cited by 82
Tumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectives
Chen, H., & Cheng, X. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s66502 · Cited by 81

Authors: Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G. J., Uhr, J. W., & Terstappen, L. W. M. M.
Affiliations: 1Immunicon Corporation, Huntingdon Valley, Pennsylvania; and
The University of Texas Southwestern Medical Center (US)
ORCID: Miller, M. Craig
Terstappen, Leon W. M. M.
Venue: Clinical Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2004-10-15
Volume: 10
Issue: 20
Pages: 6897-6904
ISSN: 1078-0432 (ISSN-L)
1557-3265
DOI: 10.1158/1078-0432.ccr-04-0378
OpenAlex: W2116483002
Cited by: 2,542
References: 30
Citations by year: 2026: 66 · 2025: 81 · 2024: 87 · 2023: 135 · 2022: 117 · 2021: 158 · 2020: 169 · 2019: 166 · 2018: 171 · 2017: 193 · 2016: 197 · 2015: 165 · 2014: 177 · 2013: 161 · 2012: 132
FWCI: 7.52
Type: journal article
Language: en
Open access: closed
Locations: Clinical Cancer Research (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Bio-sensing Technologies
Keywords: circulating tumor cells, CellSearch, metastatic carcinoma, prostate cancer, breast cancer, ovarian cancer, colorectal cancer, lung cancer, liquid biopsy
MeSH terms: Adult, Automation, Biological Assay, Carcinoma, Cytological Techniques, Female, Humans, Male, Middle Aged, Neoplastic Cells, Circulating, Neoplasm Metastasis, Sensitivity and Specificity, Reproducibility of Results, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks